TABLE 1.
Clinical characteristics of study population
All values are expressed as the mean ± S.D. or the number or percentage (in parentheses) of enrolled subjects.
| Characteristics | NSTACS (n = 84) | CSA (n = 38) | CPS (n = 60) | p |
|---|---|---|---|---|
| Age (years) | 59 ± 7.6 | 62 ± 6.8 | 60 ± 8.8 | 0.643 |
| Male/female | 56/28 | 27/11 | 36/24 | 0.504 |
| Risk factors (no. (%)) | ||||
| Hypertension | 53 (62) | 12 (32) | 12 (20) | <0.001 |
| Diabetes mellitus | 21 (25) | 9 (24) | 10 (17) | 0.473 |
| Hypercholesterolemia | 42 (50) | 19 (50) | 27 (45) | 0.818 |
| Current smoker | 47 (56) | 23 (61) | 18 (30) | 0.002 |
| Medications (no. (%)) | ||||
| Aspirin | 80 (95) | 34 (89) | 50 (83) | 0.061 |
| Clopidogrel | 76 (90) | 20 (53) | 8 (13) | <0.001 |
| β-Blockers | 32 (38) | 26 (68) | 6 (10) | <0.001 |
| Statins | 67 (80) | 29 (76) | 12 (20) | <0.001 |
| ACEI or ARBs | 28 (33) | 12 (32) | 4 (7) | 0.001 |
| Nitrates | 60 (71) | 8 (22) | 8 (13) | <0.001 |
| Antidiabetic drugs | ||||
| Insulin | 14 (17) | 5 (13) | 6 (10) | 0.515 |
| Metformin | 10 (12) | 4 (11) | 3 (5) | 0.359 |
| Repaglinide | 5 (6) | 3 (8) | 2 (3) | 0.608 |
| Acarbose | 7 (8) | 2 (5) | 3 (5) | 0.681 |